Yumirle Turmelle, M.D., M.S.P.H.  turmelley@wustl.edu

Profile picture
Associate Professor of Pediatrics, Gastroenterology, Hepatology and Nutrition
Medical Director, Pediatric Liver Transplant Program
Fellowship Program Director, Pediatric Transplant Hepatology
Director, Pediatrics Office of Faculty Development
Gastroenterology, Hepatology and Nutrition

phone: (314) 454-6173

Clinical Interests

Biliary Atresia, Neonatal Cholestasis, Pediatric Liver Transplantation


  • AB, with Honors, Miami-Dade Community College1993
  • BA, with Honors, University of Miami1995
  • MD, University of Florida College of Medicine2000
  • MSPH, Saint Louis University2014


  • Resident, University of Miami/Jackson Memorial Hospital2000 - 2003
  • Fellow, Washington University School of Medicine/St. Louis Children's Hospital2003 - 2006
  • Advance Hepatology Fellow, Washington University School of Medicine2006 - 2007

Licensure and Board Certification

  • 2003American Board Certification in Pediatrics
  • 2007American Board Certification in Pediatrics, Pediatric Gastroenterology
  • 2007MO, Physician and Surgeon License
  • 2007American Board Certification in Pediatric Gastroenterology
  • 2008UNOS Certification – Pediatric Liver Transplant Physician
  • 2010American Board Certification in Pediatrics, Pediatric Transplant Hepatology
  • 2010American Board in Pediatric Transplant Hepatology

Honors and Awards

  • Thomas Brown McClelland Trust Scholarship, Rotary Foundation of Miami1996 - 2000
  • American Heart Association Summer Student Fellowship Award1997
  • Studies of Pediatric Liver Transplantation (SPLIT) Travel Award2005
  • American Association For The Study of Liver Diseases (AASLD) - Advanced Hepatology Fellowship Award2006
  • American Gastroenterological Association (AGA) Academic Skills Workshop Travel Award2007
  • Washington University School of Medicine Faculty Diversity Grant2007 - 2010

Recent Publications view all (34)

  1. Impact of Steroid Therapy on Early Growth in Infants with Biliary Atresia: The Multicenter Steroids in Biliary Atresia Randomized Trial J Pediatr. 2018;(202):179-185. PMID:30244988  
  2. Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants. Gastroenterology. 2018. PMID:30144432  
  3. Bone Density in Children with Chronic Liver Disease Correlates with Growth and Cholestasis. Hepatology. 2018. PMID:30063078 
  4. Neurodevelopmental Outcome of Young Children with Biliary Atresia and Native Liver: Results from the ChiLDReN Study. J Pediatr. 2018;196:139-147.e3. PMCID:PMC5924604  PMID:29519540 
  5. Liver Transplantation for Malignant Primary Pediatric Hepatic Tumors. J Am Coll Surg. 2017;225(1):103-113. PMID:28232059 
  6. Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia? PLoS One. 2017;12(5):e0176275. PMCID:PMC5426590  PMID:28493866 
  7. Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis. Hepatology. 2017;65(5):1645-1654. PMCID:PMC5397365  PMID:28027587 
  8. Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia. J Pediatr. 2016;170:211-7.e1-2. PMCID:PMC4826612  PMID:26725209 
  9. Quality of Life and Its Determinants in a Multicenter Cohort of Children with Alagille Syndrome. J Pediatr. 2015. doi:10.1016/j.jpeds.2015.04.077  PMID:26059338 
  10. Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia. J Pediatr Gastroenterol Nutr. 2014;59(6):702-7. doi:10.1097/MPG.0000000000000547  PMCID:PMC4243585  PMID:25419594 
  11. Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium. J Pediatr. 2014;165(3):539-546.e2. doi:10.1016/j.jpeds.2014.05.038  PMCID:PMC4144331  PMID:25015575 
  12. Hepatic venous outflow obstruction in pediatric liver transplantation: technical considerations in prevention, diagnosis, and management. Pediatr Transplant. 2014;18(5):497-502. doi:10.1111/petr.12277  PMID:24815309 
  13. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014;311(17):1750-9. PMCID:PMC4303045  PMID:24794368 
  14. Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology. 2013;58(5):1724-31. doi:10.1002/hep.26512  PMCID:PMC3844083  PMID:23703680 
  15. Health related quality of life in patients with biliary atresia surviving with their native liver. J Pediatr. 2013;163(4):1052-7.e2. PMCID:PMC4014354  PMID:23746866 
  16. Portal hypertension in children and young adults with biliary atresia. J Pediatr Gastroenterol Nutr. 2012;55(5):567-73. doi:10.1097/MPG.0b013e31826eb0cf  PMCID:PMC3483444  PMID:22903006 
  17. Human polyomaviruses in children undergoing transplantation, United States, 2008-2010. Emerg Infect Dis. 2012;18(10):1676-9. doi:10.3201/eid1810.120359  PMCID:PMC3471627  PMID:23017293 
  18. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012;130(3):e607-14. doi:10.1542/peds.2011-1423  PMCID:PMC3428752  PMID:22891232 
  19. Neonatal cholestasis: opportunities to increase early detection. Acad Pediatr. 2012;12(4):283-7. doi:10.1016/j.acap.2012.03.021  PMCID:PMC3398230  PMID:22634076 
  20. Management of excluded bile ducts in paediatric orthotopic liver transplant recipients of technical variant allografts. HPB (Oxford). 2011;13(12):893-8. doi:10.1111/j.1477-2574.2011.00394.x  PMCID:PMC3244630  PMID:22081926 
  21. PedsQL™ Cognitive Functioning Scale in pediatric liver transplant recipients: feasibility, reliability, and validity. Qual Life Res. 2011;20(6):913-21. PMCID:PMC3763499  PMID:21184184 
  22. Small bowel obstruction after pediatric liver transplantation: the unusual is the usual. J Am Coll Surg. 2011;212(1):62-7. doi:10.1016/j.jamcollsurg.2010.09.017  PMID:21123094 
  23. Biliary strictures in pediatric liver transplant recipients - early diagnosis and treatment results in excellent graft outcomes. Pediatr Transplant. 2010;14(3):358-63. doi:10.1111/j.1399-3046.2009.01246.x  PMID:20003138 
  24. The role of liver transplantation for hepatic adenomatosis in the pediatric population: case report and review of the literature. Pediatr Transplant. 2010;14(3):E16-9. doi:10.1111/j.1399-3046.2008.01123.x  PMID:19490491 
  25. Towards minimizing immunosuppression in pediatric liver transplant recipients. Pediatr Transplant. 2009;13(5):553-9. doi:10.1111/j.1399-3046.2008.01061.x  PMID:19067920 
  26. p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology. 2009;50(1):207-15. doi:10.1002/hep.22979  PMCID:PMC2705473  PMID:19441104 
  27. Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant. 2009;13(2):223-30. doi:10.1111/j.1399-3046.2008.00998.x  PMCID:PMC2659723  PMID:18643912 
  28. Ibuprofen-induced liver injury in an adolescent athlete. Clin Pediatr (Phila). 2009;48(1):84-6. doi:10.1177/0009922808320797  PMID:18626108 
  29. Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol Immunol. 2008;45(11):3125-32. doi:10.1016/j.molimm.2008.03.008  PMCID:PMC2600895  PMID:18452991 
  30. The effect of recipient-specific surgical issues on outcome of liver transplantation in biliary atresia. Am J Transplant. 2008;8(6):1197-204. doi:10.1111/j.1600-6143.2008.02223.x  PMID:18444930 
  31. Prolonged neonatal jaundice and the diagnosis of biliary atresia: a single-center analysis of trends in age at diagnosis and outcomes. Pediatrics. 2008;121(5):e1438-40. doi:10.1542/peds.2007-2709  PMID:18443020 
  32. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant. 2008;8(2):396-403. doi:10.1111/j.1600-6143.2007.02068.x  PMID:18162090 
  33. Biliary atresia: a mostly preventable disease? J Gastroenterol Hepatol. 2008;23(1):3-4. doi:10.1111/j.1440-1746.2007.05235.x  PMID:18171336 
  34. Rosiglitazone inhibits mouse liver regeneration. FASEB J. 2006;20(14):2609-11. doi:10.1096/fj.06-6511fje  PMID:17077279 
Last updated: 11/01/2018
© 2020 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130